Search Within

Santosha Adipudi Vardhana

Formats
  1. Meeting Abstract (43)
  2. Journal Article (37)
  3. Editorial (9)
  4. Research Letter (6)
  5. Review (5)
  6. Conference Paper (2)
Groups
  1. Center for Hematologic Malignancies (102)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (102)
  3. Department of Medicine (102)
  4. GSK Faculty (102)
  5. Hematologic Malignancies, Division of (102)
  6. Human Oncology and Pathogenesis Program (102)

More Groups

People
  1. Alison Moskowitz (36)
  2. Steven Horwitz (33)
  3. Andrew Zelenetz (32)
  4. Anita Kumar (32)
  5. Ariela Noy (30)
  6. Maria Palomba (28)

More People

Years
  1. 2025 (4)
  2. 2024 (15)
  3. 2023 (29)
  4. 2022 (18)
  5. 2021 (13)
  6. 2020 (10)

More Years

Publications
  1. Blood (29)
  2. Journal of Clinical Oncology (10)
  3. Hematological Oncology (5)
  4. Annals of Surgical Oncology (4)
  5. Blood Advances (4)
  6. Annals of Surgery (3)

More Publications

Publishers
  1. American Society of Hematology (33)
  2. American Society of Clinical Oncology (11)
  3. Nature Publishing Group (9)
  4. Cell Press (8)
  5. American Association for Cancer Research (6)
  6. Elsevier Inc. (6)

More Publishers

Results (102)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immune signature of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Ganesan, N.; Shah, G. L.; Wong, P.; Argyropoulos, K. V.; Sen, F.; Dogan, A.; Straus, D. J.; Noy, A.; Kumar, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Emapalumab for malignancy-associated hemophagocytic lymphohistiocytosis: The Memorial Sloan Kettering Cancer Center experience
    Meeting Abstract

    Johnson, W. T.; Epstein-Peterson, Z. D.; Ganesan, N.; Chang, T.; Galasso, N.; Stuver, R.; Khan, N.; Salles, G.; Moskowitz, A. J.; Vardhana, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Discordant SARS-CoV-2 spike protein receptor binding domain IgG and neutralization after B-cell depletion
    Journal Article

    Noy, A.; Vardhana, S. A.
    Haematologica (2022)

    Fulltext@MSK | Save
  • Not so neutral lipids: Metabolic regulation of the pre-metastatic niche
    Editorial

    Schoenfeld, J. D.; Vardhana, S. A.
    Cell Metabolism (2022)

    Fulltext@MSK | Save
  • Understanding T cell responses to COVID-19 is essential for informing public health strategies
    Review

    Vardhana, S.; Baldo, L.; Morice, W. G. 2nd; Wherry, E. J.
    Science Immunology (2022)

    Fulltext@MSK | Save
  • SARS-CoV-2 in immunocompromised individuals
    Review

    DeWolf, S.; Laracy, J. C.; Perales, M. A.; Kamboj, M.; van den Brink, M. R. M.; Vardhana, S.
    Immunity (2022)

    Fulltext@MSK | Save
  • A novel microbiome signature in gastric cancer: A two independent cohort retrospective analysis
    Conference Paper

    Abate, M.; Vos, E.; Gonen, M.; Janjigian, Y. Y.; Schattner, M.; Laszkowska, M.; Tang, L.; Maron, S. B.; Coit, D. G.; Vardhana, S.; more...
    Lippincott Williams & Wilkins (2022)

    Fulltext@MSK | Save
  • Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses
    Journal Article

    Lyudovyk, O.; Kim, J. Y.; Qualls, D.; Hwee, M. A.; Lin, Y. H.; Boutemine, S. R.; Elhanati, Y.; Solovyov, A.; Douglas, M.; Chen, E.; more...
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Long and persistent COVID-19 in patients with hematologic malignancies: From bench to bedside
    Review

    Laracy, J. C.; Kamboj, M.; Vardhana, S. A.
    Current Opinion in Infectious Diseases (2022)

    Fulltext@MSK | Save
  • Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence
    Journal Article

    Belk, J. A.; Yao, W.; Ly, N.; Freitas, K. A.; Chen, Y. T.; Shi, Q.; Valencia, A. M.; Shifrut, E.; Kale, N.; Yost, K. E.; more...
    Cancer Cell (2022)

    Fulltext@MSK | Save